The interaction between Streptococcus pyogenes and the host cell surface is not completely understood. Characterization of the adhesion mechanisms of the bacterium to the host cell surface is needed in order to develop new vaccines and anti-adhesion drugs. The presence of glycoprotein-binding activities among streptococcal strains was investigated. An activity binding to thyroglobulin, fetuin, asialofetuin and mucin but not non-glycosylated proteins was found to be present in the majority of the S. pyogenes strains studied. Cross-inhibition experiments suggested that the glycoproteins share a common structure recognized by the bacteria. The glycoprotein-binding activity was found to be proteinaceous, tightly attached to the bacterial surface and it also mediated the adherence of bacteria to solid surfaces coated with glycoproteins. The activity was found by transposon mutagenesis and complementation to be regulated by the multiple-gene regulator Mga, which has been implicated as a regulator of S. pyogenes virulence factors.
INTRODUCTION
Streptococcus pyogenes is an important human pathogen causing a wide variety of infections ranging from tonsillitis, impetigo and erysipelas to severe life threatening infections like necrotizing fasciitis and sepsis, which have increased in number during the last few years (Chelsom et al., 1994) . This drives us to look for new preventive methods and therapies. Characterization of the molecular basis of interactions between S. pyogenes and the host could provide us with new candidate vaccines. Furthermore, novel anti-adhesive drugs could be developed using analogues of receptor molecules to prevent the bacteria from binding to host cells (Karlsson, 1995 ; Beuth et al., 1996 ; Zopf & Roth, 1996) .
The adherence of bacteria to host cells is in many cases mediated by lectin-like adhesins on the bacterial surface binding to carbohydrate receptors (Beachey, 1981 ; & Sharon, 1990) , which are present on the host cell surface as part of the membrane glycoproteins and glycolipids. Escherichia coli is known to bind at least to eight different carbohydrate structures via its surface proteins (Karlsson, 1995 ; Sharon, 1996 ; Sharon & Lis, 1997) . Some of the carbohydrate structures have been used to inhibit the binding of Esc. coli to the host intestinal epithelia (Mouricout et al., 1990) . Likewise, streptococcal infections of the human pharyngeal epithelia, where local administration of the drug to the infection focus would be easy to carry out, would be a suitable target for anti-adhesive therapy. Unfortunately, very little is known about the streptococcal receptors on host cells.
A number of S. pyogenes surface proteins interacting with the human host have been identified. Some of these, like the fibronectin-binding proteins (Talay et al., 1991 (Talay et al., , 1992 Courtney et al., 1992 Courtney et al., , 1994 Kreikemeyer et al., 1995 ; Rakonjac et al., 1995 ; Jaffe et al., 1996 ; Rocha & Fischetti, 1999) , are adhesins, while others, for example M-like proteins (Cleary & Retnoningrum, 1994) and C5a peptidase (Chen & Cleary, 1990) , are protective against the host immunodefence system. M-protein has a dual role, being the major antiphagocytic factor of S. pyogenes and also an adhesin that binds fibronectin, fibrinogen and albumin, among others (Fischetti et al., 1988 ; Schmidt et al., 1993 ; Gubbe et al., 1997) . The ability of S. pyogenes to infect and to persist in varied locations of the human host is in part controlled by the multiple-gene regulator of S. pyogenes, Mga, which controls the expression of the M-protein (emm), M-like proteins (fcrA, enn, sph) and C5a peptidase (scpA) genes (Podbielski et al., 1996a) . These genes are located in one regulon where the transcription of the genes downstream of the mga gene is monocistronically regulated. The genes encoding the opacity factor (sof), secreted inhibitor of the complement cascade (sic) and streptococcal cysteine protease (speB) are also regulated by Mga (Podbielski et al., 1996a) .
The purpose of the present study was to characterize glycoprotein-binding specificities of streptococci to understand the interaction between the bacteria and the potential carbohydrate receptor structures of the host cell surface. A glycoprotein-binding adhesion activity was shown to be present in the majority of the S. pyogenes strains studied. Using transposon mutagenesis, the novel glycoprotein-binding activity was shown to be regulated by Mga.
METHODS
Bacterial strains and culture conditions. Streptococcus pyogenes clinical isolate A8173 (type M2) and group D streptococci (D1213, D1263, D1448, D1470, D7637, D7883) were provided by K. Kunnas, National Department of Health, Kuopio, Finland. S. pyogenes (Tyks 2\8-114, Tyks3\7-150, Kuo 36\5623, OHI R5\65G and SAN R67\32), group C (Cstrept 5\95, C-strept 13\95, C-strept 21\95, C-strept 120\95, C-strept 164\95 and C-strept 200\95) and group G streptococci (G-strep 1\95, G-strep 37\95, G-strep 59\95, G-strep 5\95, G-strep 38\95 and G-strep 74\95) were isolated from throat, wound or blood and were provided by P. Huovinen, National Department of Health, Turku, Finland (Kataja et al., 1998a, b) . S. pyogenes M2 71-676 wild-type and mutant strains (Podbielski et al., 1996b ; Schmidt et al., 1997) were kindly provided by A. Podbielski, University Hospital Ulm, Ulm, Germany and S. pyogenes CS101 and mutant strains by M. Boyle, Medical College of Ohio, Toledo, USA (Podbielski et al., 1996b) . Escherichia coli JM109 was obtained from Promega.
Streptococcal strains and Enterococcus faecalis were grown on Todd-Hewitt (Difco) plates or media supplemented with 0n5 % yeast extract (THY ; Biokar Diagnostics). Esc. coli was grown in Luria broth. All cultures were incubated at 37 mC in ambient air unless otherwise stated. All bacteria were stored at k70 mC in growth medium containing 15 % (v\v) glycerol. The M2 71-676 and CS101 pSF152 mutants were grown in the presence of 60 µg spectinomycin ml − ". Recombinant Esc. coli JM109 was grown with 60 µg carbenicillin ml − ".
Materials. Bovine and porcine thyroglobulin, bovine fetuin and asialofetuin, bovine submaxillar mucin, horse myoglobin, bovine erythrocyte carbonic anhydrase, BSA, trypsin, chickenegg-white trypsin inhibitor, streptavidin-HRP (horse radish peroxidase), diaminobenzidine, lysozyme, spectinomycin, streptomycin, tetracycline and carbenicillin were purchased Glycoprotein-binding assay. Bacteria grown overnight on THY plates were collected and washed twice by centrifugation in PBS and adjusted to a concentration that gave an OD '!! of 0n5 with a Beckman DU 640 spectrophotometer and 1 cm path length cuvettes. Aliquots of 1 µl were pipetted onto gridded nitrocellulose membrane and nonspecific binding sites were saturated with 3 % BSA, 0n1 % Tween 20 in PBS at room temperature for 1 h. The biotinylated ligand was added to the membrane in 0n1 % Tween 20 in PBS to give a final concentration of 0n3-1n0 µg ml − " and incubated at room temperature for 30 min. The membrane was washed three times with PBS, and 0n1 µg ml − " streptavidin-HRP was added to the membrane in 0n1 % Tween 20 in PBS and incubated at room temperature for 30 min. The membrane was washed as above and the binding of the ligand was detected by ECL autoradiography. In inhibition experiments, the membrane containing a dilution series of the bacteria (corresponding to OD '!! 4n0-0n125) was preincubated with excess ligand at 1 mg ml − " in 0n1 % Tween 20 in PBS for 30 min, the biotinylated ligand was added directly to the preincubation solution and the incubation was continued for 30 min. The binding of the ligand was detected as above. The results shown in Tables 1, 2 and 3 are given as the reciprocal of the binding titre, defined as the last dilution showing clearly visible binding.
Trypsin treatment and extractions. Bacteria grown and harvested under standard conditions were digested with trypsin at concentrations of 0n01-100 µg ml − " for 30 min at 37 mC, after which the digestion was terminated with trypsin inhibitor. In other experiments, the bacteria were suspended in PBS containing 2 M NaCl, 1 % Triton X-100 or 10 mM DTT and incubated at room temperature for 1 h, or resuspended in PBS and kept at 80 mC for 30 min. After the treatments the bacteria were pelleted by centrifugation, washed twice and resuspended in PBS.
Binding of radiolabelled streptococci to thyroglobulin on microtitre plates. Bacteria were grown in 15 ml THY broth containing 0n5 mCi (18n5 MBq) Tran$&S-label at 37 mC overnight. The bacteria were concentrated by centrifugation (3 000 g for 10 min at 4 mC) to 1 ml PBS and the unbound label was removed by centrifuging the bacteria as above through 5 ml 6 % BSA in PBS. Microtitre plate wells were coated with 100 µl of the ligand at 10 µg ml − " at 37 mC for 2 h. The wells were rinsed with PBS and saturated with 2 % BSA, 0n1% Tween 20 in PBS for 1 h at room temperature. The wells were overlaid with 100 µl bacteria in 0n1 % BSA, 0n05 % Tween 20 in PBS at a concentration that gave an OD '!! of 0n3 (" 4i10) c.f.u. ml − "), incubated for 1n5 h at 37 mC with gentle agitation and washed three times for 10 min with 200 µl PBS per well. In inhibition experiments, the bacteria were preincubated with excess ligand at 1 mg ml − " in 0n1 % BSA, 0n05 % Tween 20 in PBS for 30 min and then added to the wells. Binding of the bacteria to wells coated with 2 % BSA was used as control. Experiments were carried out in 12 parallel wells. The bound bacteria were detected using a liquid-scintillation counter.
Conventional DNA techniques. Plasmid DNA preparation from Esc. coli, restriction enzyme digestions, ligations, transformations, agarose gel electrophoresis and Southern blotting were performed as described by Sambrook et al. (1989) . Chromosomal S. pyogenes DNA was prepared as described by .
Transposon mutagenesis and analysis of the mutants.
Transposon mutagenesis was performed as described by . Briefly, a spontaneous streptomycinresistant S. pyogenes strain (A8173sr) was grown overnight in 100 ml THY broth containing 1 mg streptomycin ml − " at 37 mC. Donor strain Ent. faecalis CG110 (provided by D. Clewell, University of Michigan, Ann Arbor, USA) was grown similarly in 10 ml THY broth containing 10 µg tetracycline ml − ". Bacteria were harvested and A8173sr was resuspended in 1 ml THY. Ent. faecalis was resuspended in 10 ml THY. One millilitre of both suspensions were mixed together, plated on THY plates (no antibiotics) and grown overnight at 37 mC. Bacteria were collected from the overnight culture, plated on THY plates containing 1 mg streptomycin ml − " and 5 µg tetracycline ml − " and grown for 48 h at 37 mC. Colonies were blotted onto nitrocellulose membranes and were analysed by the glycoprotein-binding assay using diaminobenzidine as substrate. The number of transposons integrated into the genomes of the non-binding mutants was determined by Southern hybridization of HindIII-digested genomic DNAs using [α-$#P]dCTP-labelled plasmid pAM120 (which carries the whole Tn916 transposon ; provided by D. Clewell) as the probe.
Cloning of the Tn916-chromosomal DNA junction fragment.
Chromosomal DNA from Streptococcus pyogenes mutated with Tn916 was cleaved with HindIII and the fragments were separated by agarose gel electrophoresis. A 14 kb fragment containing the 5h end of Tn916 was extracted from the gel, cleaved with HincII and ligated to pBS13j (Promega) The ligation mixture was transformed into Esc. coli JM109, the bacteria were grown overnight and the colonies transferred to a nylon membrane. The membrane was probed with [γ-$#P]ATP labelled oligonucleotide Tn1 (5h-GAGTGGTTTTG-ACCTTGATA-3h) which binds to the 5h end of Tn916 at position 53-72. Plasmid DNA from hybridizing colonies was prepared and the DNA sequenced.
DNA sequencing. DNA was sequenced with a Sequenase 2.0 kit according to the instructions of the manufacturer. Primer Tn1 was used in sequencing reactions. The products were analysed by gel electrophoresis and visualized by autoradiography. The sequence data were analysed with DNAstar software.
Generation of an mga-complemented strain. Plasmid pJRS2050 (Andersson et al., 1996 ; carries mga and associated regulatory sequences in pLZ12-Spec ; provided by J. Scott, Emory University Health Sciences Center, Atlanta, USA) was electroporated into A8173-1 to generate A8173-1(pJRS2050). The electroporation method described by Simon & Ferretti (1991) was used with one modification : THY medium was used instead of Todd-Hewitt supplemented with horse serum. As a control, the plasmid pLZ12-Spec (an Esc. coli-S. pyogenes shuttle vector) was introduced into A8173-1 to generate A8173-1(pLZ12-Spec).
RESULTS

Binding of glycoproteins to streptococci
To characterize the interaction between streptococci and carbohydrates, an assay to study the binding of glycoproteins to streptococci was developed. The assay is based on the binding of biotinylated ligands to bacterial dots on a nitrocellulose membrane and the detection of the bound ligand by streptavidin-HRP and ECL autoradiography. The glycoproteins used in the assay containing a wide selection of N-linked complex, high-mannose and O-linked glycans were bovine thyroglobulin, bovine fetuin and asialofetuin, and bovine submaxillar mucin (Spiro & Bhoyroo, 1974 ; Yet et al., 1988 ; Strous & Dekker, 1992 ; Rawitch et al., 1993) . Horse myoglobin and bovine erythrocyte carbonic anhydrase were used as controls representing nonglycosylated proteins.
Six S. pyogenes strains representing different infection foci and different geographical origins, six streptococcal strains from the Lancefield groups C and G (wound and throat infections) and six strains from group D were analysed for binding to glycoprotein ligands. Thyroglobulin, fetuin and asialofetuin bound to several S. pyogenes, group C and group G strains, and submaxillary mucin to S. pyogenes and group C strains (Fig.  1) . No binding of the control non-glycosylated proteins horse myoglobin and carbonic anhydrase to the bacteria was detected.
Inhibition assays were carried out using excess ligand to inhibit the binding of the glycoproteins to a dilution series of S. pyogenes A8173 on nitrocellulose membranes (Table 1) . As expected, the binding of biotinylated thyroglobulin to A8173 was abolished when excess bovine thyroglobulin was used as inhibitor, and similar inhibition was obtained with human and porcine thyroglobulin (data not shown). However, fetuin, mucin and asialofetuin inhibited the binding of thyroglobulin to half or less. Binding of fetuin to the bacteria was in turn abolished with excess thyroglobulin, and reduced to half or less when incubated with excess fetuin, mucin or asialofetuin. Likewise, binding of mucin was abolished when excess thyroglobulin was used as inhibitor. Fetuin had no effect on the binding of mucin, but asialofetuin and mucin reduced the binding to half or less. Binding of asialofetuin was abolished with excess thyroglobulin, almost abolished with fetuin and asialofetuin and reduced to half with mucin. The crossinhibitions suggest the presence of a common structural component in the glycoproteins recognized by the bacteria. On the other hand, the partial cross-inhibitions suggest the presence of one or more additional binding targets not shared by all of the glycoproteins. Membranes containing dilution series of S. pyogenes A8173 were preincubated with 1 mg ml −" of the inhibitory ligand before addition of the biotinylated binding ligand at 0n3 µg ml −" (thyroglobulin) or 1n0 µg ml −" (fetuin, asialofetuin and submaxillary mucin). Results are given as the reciprocal of the binding titre (-, no binding). dilution series of the bacteria was analysed (Table 2) . Trypsin digestion of the bacteria using different enzyme concentrations either reduced or abolished the binding activity, which suggests that the interaction is mediated by a protein on the bacterial surface. Incubation of the bacteria at 80 mC or in the presence of 2 M NaCl, 10 mM DTT or 1 % Triton X-100 had only a minor effect on the thyroglobulin-binding activity, which indicated that the protein is heat stable and tightly attached to the surface of the bacteria.
Inhibitory ligand
Adhesion of bacteria to immobilized ligands
Adhesion of bacteria to thyroglobulin immobilized on microtitre plate wells was investigated to find out whether the glycoprotein-binding activity could support the adhesion of bacteria to glycan-containing surfaces. Metabolically labelled bacteria adhered to the wells coated with thyroglobulin, and the adhesion was inhibited with excess ligand (Fig. 2a) . Essentially, no binding was detected to the control BSA-coated surface. These results indicate that S. pyogenes can adhere to surfaces coated with thyroglobulin.
Transposon mutagenesis and analysis of the mutants
Transposon mutagenesis of wild-type strain A8173 was carried out in an attempt to identify the gene that encodes the binding activity. Transposon-harbouring mutants (" 4 000 colonies) were screened by blotting the mutant colonies onto nitrocellulose membranes and probing them for their binding activity using thyro- HindIII-digested genomic DNA with plasmid pAM120 (Fig. 4) . A 14 kb fragment of the A8173-1 genomic DNA that contained the 5h end of Tn916 was cloned. The DNA was sequenced and the insertion locus was found to be in the mga gene at position 2076 in the previously published sequence (Podbielski et al., 1995) .
Binding activity in an mga-complemented strain and mga regulon mutants
To confirm that the mutation in the mga gene was responsible for the loss of S. pyogenes A8173 glycoprotein-binding activity, the mutant strain was complemented for mga expression with the plasmid pJRS2050, which carries all of mga and the regulatory region upstream of mga in the Esc. coli-S. pyogenes shuttle vector pLZ12-Spec (Andersson et al., 1996) . The binding of the glycoproteins to dilution series of the complemented strain A8173-1(pJRS2050) was compared with the binding to the wild-type A8173 and the mutant A8173-1 strains (Fig. 3) . Introduction of the mga gene Podbielski et al. (1996b) and Schmidt et al. (1997) . † Binding activity of biotinylated thyrogobulin on serially diluted bacteria is expressed as the reciprocal of the binding titre (-, no binding). partly restored the thyroglobulin binding activity, while the control plasmid pLZ12-Spec had no effect.
Further evidence for the dependence of the S. pyogenes A8173 glycoprotein-binding activity on Mga was obtained by analysing independent, previously characterized mga mutants for their binding to thyroglobulin.
As with the A8173 strain, thyroglobulin bound to the M2 71-676 and CS101 wild-type strains. Thyroglobulin showed no binding to the mga gene insertion mutants of these strains (Table 3 ). In contrast, binding of thyroglobulin to the emm and fcr mutants of M2 71-676, and to a mrp mutant of CS101 was as strong as to the parental strains, which indicated that neither the Mprotein nor the IgG-binding protein, which are regulated by the mga gene, is responsible for the binding activity.
Prevalence of the binding activity
Prevalence of the binding activity among S. pyogenes was investigated by studying the binding of thyroglobulin to 46 S. pyogenes strains. The activity was present in at least 32 of the 46 strains studied (Fig. 5) . There appeared to be no major difference in the presence of the activity between bacteria from various infection foci (throat, skin and blood), opacity factor positive and negative strains or strains of different T serotypes (not shown), or from different geographical origins (Finland, USA, Spain).
DISCUSSION
The issue of Streptococcus pyogenes adherence to human epithelial cells is only just beginning to be understood. Some of the S. pyogenes surface components have been identified that mediate the binding of the bacteria to the host epithelial cells, but little is known about the host cell-surface receptors recognized by S. pyogenes. The fibronectin-binding adhesin SfbI\ protein F1 has proven to be important in the adherence of the bacteria to host respiratory epithelial cells and to extracellular matrix fibronectin. In addition, these proteins have been demonstrated to promote the invasion of S. pyogenes into host cells Talay et al., 1992 ; Sela et al., 1993 ; Ozeri et al., 1996 Ozeri et al., , 1998 Molinari et al., 1997 ; Jadoun et al., 1998) . Some studies suggest that M-protein mediates adherence of S. pyogenes to epithelial cells and that the receptor structure would be a fucose-containing oligosaccharide of the type found on HEp-2 cells (Tylewska et al., 1988 ; Wang & Stinson, 1994a, b) . Other studies demonstrate no difference in the binding of an S. pyogenes strain and its M-protein defective derivative to human buccal and tonsillar epithelia . It has also been proposed that the S. pyogenes hyaluronic acid capsule, which is present on the surface of the most of S. pyogenes strains, may serve as a universal mediator of attachment to human keratinocytes of the pharyngeal mucosa and the skin (Schrager et al., 1998) . A hypothetical two-step model where bacterial surface lipoteichoic acid (LTA) has a key role has been proposed for the interaction of streptococci and host cells . This model combines the LTA-mediated weak and reversible adherence of the bacteria to the cells with the strong and irreversible binding between fibronectin-binding proteins and fibronectin, or M-protein and an M-protein receptor.
Cell adhesion mechanisms characterized for other streptococci include the interactions between Streptococcus pneumoniae and the oligosaccharide structures Galβ1-4GlcNAcβ1-3Galβ1-4Glc (Andersson et al., 1983) , GalNAcβ1-4Galβ1- (Krivan et al., 1988) , GalNAcβ1-3Galα1-4Galβ1-4Glc-Cer (Cundell & Tuomanen, 1994) and NeuAcα2-3\6Galβ1- (Barthelson et al., 1998) (Liukkonen et al., 1992 ; Haataja et al., 1993 Haataja et al., , 1994 . Streptococcus sanguis expresses the SSP-5 adhesin, which mediates binding to sialic acid-containing salivary glycoproteins (Demuth et al., 1988 (Demuth et al., , 1990 . Anti-adhesion experiments have been carried out in animal models using lacto-N-neo-tetraose and its derivatives to attenuate the course of pneumococcal pneumonia and to prevent colonization of the nasopharynx (Ida$ npa$ a$ n-Heikkila$ et al., 1997 ; Barthelson et al., 1998 et al., 1993) and bovine submaxillary mucin mainly O-linked glycans (Strous & Dekker, 1992) . Fetuin is glycosylated with both N-and O-linked sialic acid-containing oligosaccharides (Spiro & Bhoyroo, 1974 ; Yet et al., 1988) . Preliminary experiments using a selection of mono-, di-and trisaccharides as inhibitors of binding did not reveal the binding specificity of the adhesin (P. Isoma$ ki & J. Finne, unpublished results). The receptor structure could therefore be a more complex or extended structure included in the N-and\or O-glycans of these glycoproteins, or a structure not apparent in gross peptide sequence comparison analysis. As indicated by the resistance of the binding protein to solubilizations by salt, detergent, reducing agent and heat treatment, it appears to be tightly anchored to the bacterial surface. Only trypsin digestion removed the activity from the bacteria. These physical characteristics parallel those described for some other streptococcal surface proteins like streptococcal surface dehydrogenase, which was shown to be resistant to 2 % SDS and 2 M NaCl treatments but sensitive to trypsin digestion (Pancholi & Fischetti, 1992) . Unfortunately, analysis of the trypsin extract of streptococci revealed that the activity was rapidly inactivated and the molecule was therefore not amenable to further purification. In transposon-mutagenesis experiments, the adhesioninactivating insertion was found to be in the mga gene. The finding that the S. pyogenes binding-activity expression is controlled by the mga gene was confirmed by studying the adhesion of the glycoproteins to independent mga mutant strains, and by complementation with a wild-type mga gene. That the complementation was partial may be related to the fact that the mga gene used originated from another strain of S. pyogenes. On the other hand, there was binding of the glycoproteins to mutant strains deficient in M-protein and IgG-binding protein, which indicates that these proteins do not mediate the binding activity. The fact that the mga gene is a regulator of important S. pyogenes virulence factors, together with the high prevalence of the glycoproteinbinding activity among S. pyogenes and group C and G strains, suggests that it may have a role in the pathogenicity of streptococci. Further studies including the cloning of the gene are needed in order to characterize the molecular properties of this ' strepadhesin ' activity, its receptor specificity and its role in streptococcal virulence.
